Inventor · disambiguated record
Shaei Y. Huang
Also filed as: HUANG SHAEI Y
4 granted patents·9 pending applications·75 citations·filing 1999–2009
77Inventor score
Top patents by PatentIndex Score
13 records- 0188US7501435B2Inhibitors of checkpoint kinasesMERCK & CO INC·Filed 2007·Granted Mar 10, 2009·8 cites·5 claims
- 0285US7125865B2Therapeutic compounds for treating dyslipidemic conditionsMERCK & CO INC·Filed 2003·Granted Oct 24, 2006·21 cites·19 claims
- 0382US6699899B1Substituted acylhydroxamic acids and method of reducing TNFα levelsCELGENE CORP·Filed 1999·Granted Mar 2, 2004·45 cites·26 claims
- 0463US7345062B2Substituted acylhydroxamic acids and method of reducing TNFαlevelsCELGENE CORP·Filed 2004·Granted Mar 18, 2008·1 cites·6 claims
- 0560US2008280967A1Substituted acylhydroxamic acids and method of reducing TNFalpha levelsCELGENE CORP·Filed 2008·Application pending·0 cites
- 0653US2011124661A1Oxazolobenzimidazole derivativesMERCK SHARP & DOHME·Filed 2009·Application pending·0 cites
- 0742US2005113419A1Therapeutic compounds for treating dyslipidemic conditionsFiled 2004·Application pending·0 cites
- 0842US2008280902A1Inhibitors of Checkpoint KinasesFRALEY MARK E·Filed 2006·Application pending·0 cites
- 0941US2008004259A1Inhibitors of Checkpoint KinasesARRINGTON KENNETH L·Filed 2006·Application pending·0 cites
- 1040US2009258852A1Inhibitors of Checkpoint KinasesARRINGTON KENNETH L·Filed 2006·Application pending·0 cites
- 1140US2005014807A1Therapeutic compounds for treating dyslipidemic conditionsFiled 2002·Application pending·0 cites
- 1238US2004266849A1Therapeutic compounds for treating dyslipidemic conditionsFiled 2002·Application pending·0 cites
- 1338US2006178398A1Therapeutic compounds for treating dyslipidemic conditionsADAMS ALAN D·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shaei Y. Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →